{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:49:03Z","timestamp":1771627743493,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf00399099","type":"journal-article","created":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T18:13:26Z","timestamp":1098382406000},"page":"84-87","source":"Crossref","is-referenced-by-count":34,"title":["Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans"],"prefix":"10.1007","volume":"36","author":[{"given":"B.","family":"Ludvik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Clodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Capek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hartter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Prager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","volume":"5","author":"EL Opie","year":"1900","unstructured":"Opie EL (1900) On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med 5: 397?428","journal-title":"J Exp Med"},{"key":"CR2","first-page":"49","volume":"38","author":"JC Ehrlich","year":"1961","unstructured":"Ehrlich JC, Ratner JM (1961) Amyloidosis of the islets of Langerhans: a restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Pathol 38: 49?59","journal-title":"Am J Pathol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF00274799","volume":"30","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887?892","journal-title":"Diabetologia"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic rat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881?3885","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJS Cooper","year":"1987","unstructured":"Cooper GJS, Willis A, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628?8632","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","volume":"32","author":"A Lukinius","year":"1989","unstructured":"Lukinius A, Wilander E, Westermark GT, Engstr\u00f6m U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32: 240?244","journal-title":"Diabetologia"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"S Kahn","year":"1990","unstructured":"Kahn S, D'Alessio DA, Schwartz MW et al. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by B cells. Diabetes 39: 634?638","journal-title":"Diabetes"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00404025","volume":"34","author":"E Hartter","year":"1991","unstructured":"Hartter E, Svoboda T, Ludvik B et al. (1991) Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34: 52?54","journal-title":"Diabetologia"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/diab.39.5.639","volume":"39","author":"T Mitsukawa","year":"1990","unstructured":"Mitsukawa T, Takemura J, Asai J et al. (1990) Islet amyloid polypeptide response to glucose, insulin and somatostatin analogue administration. Diabetes 39: 639?642","journal-title":"Diabetes"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diab.39.6.752","volume":"39","author":"PC Butler","year":"1990","unstructured":"Butler PC, Chou J, Carter WB et al. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752?756","journal-title":"Diabetes"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diab.40.12.1615","volume":"40","author":"B Ludvik","year":"1991","unstructured":"Ludvik B, Lell B, Hartter E, Schnack C, Prager R (1991) Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Diabetes 40: 1615?1619","journal-title":"Diabetes"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","volume":"34","author":"T Sanke","year":"1991","unstructured":"Sanke T, Hanabusa T, Nakano Y et al. (1991) Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 129?132","journal-title":"Diabetologia"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0006-291X(89)92529-1","volume":"160","author":"H Ohsawa","year":"1989","unstructured":"Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H, Yoshida S (1989) Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun 160: 961?967","journal-title":"Biochem Biophys Res Commun"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"B Leighton","year":"1988","unstructured":"Leighton B, Garth JS, Cooper GJS (1988) Pancreatic amylin and calcitonin gene related peptide (CGRP) cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632?635","journal-title":"Nature"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diab.39.2.260","volume":"39","author":"JM Molina","year":"1990","unstructured":"Molina JM, Cooper GJS, Leighton B, Olefsky JM (1990) Induction of insulin resistance in vivo by amylin and calcitonin generelated peptide. Diabetes 39: 260?265","journal-title":"Diabetes"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00401051","volume":"33","author":"R Sowa","year":"1990","unstructured":"Sowa R, Sanke T, Hirayama J et al. (1990) Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118?120","journal-title":"Diabetologia"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2337\/diab.39.7.871","volume":"39","author":"S Nagamatsu","year":"1990","unstructured":"Nagamatsu S, Caroll RJ, Grodsky GM, Steiner DF (1990) Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes 39: 871?874","journal-title":"Diabetes"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00401050","volume":"33","author":"D Bretherton-Watt","year":"1990","unstructured":"Bretherton-Watt D, Gilbey SG, Ghatei MA, Beacham J, Bloom SR (1990) Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man. Diabetologia 33: 115?117","journal-title":"Diabetologia"},{"key":"CR19","first-page":"694","volume":"8","author":"B Ludvik","year":"1990","unstructured":"Ludvik B, Berzlanovich A, Hartter E, Lell B, Prager R, Graf H (1990) Increased amylin levels in patients on chronic hemodialysis. Neph Dial Transpl 8: 694?695 (Abstract)","journal-title":"Neph Dial Transpl"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/diab.40.8.1005","volume":"40","author":"K Inoue","year":"1991","unstructured":"Inoue K, Hisatomi A, Umeda F, Nawata H (1991) Release of amylin from perfused rat pancreas in response to glucose arginine, ?-hydroxybutyrate, and gliclazide. Diabetes 40: 1005?1009","journal-title":"Diabetes"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF00297454","volume":"32","author":"D Bretherton-Watt","year":"1989","unstructured":"Bretherton-Watt D, Ghatei MA, Bloom SR et al. (1989) Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia 32: 881?883","journal-title":"Diabetologia"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.40.12.1701","volume":"40","author":"TD O'Brien","year":"1991","unstructured":"O'Brien TD, Westermark P, Johnson KH (1991) Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes 40: 1701?1706","journal-title":"Diabetes"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-2607(86)90106-9","volume":"23","author":"G Pacini","year":"1986","unstructured":"Pacini G, Bergman RN (1986) MINMOD: computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comp Meth Progr Biomed 23: 113?122","journal-title":"Comp Meth Progr Biomed"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0140-6736(90)90966-9","volume":"I","author":"E Hartter","year":"1990","unstructured":"Hartter E, Svoboda T, Lell B et al. (1990) Reduced islet amyloid polypeptide in insulin-dependent diabetes mellitus. Lancet I:854 (Letter)","journal-title":"Lancet"},{"key":"CR25","first-page":"245","volume":"135","author":"KH Johnson","year":"1989","unstructured":"Johnson KH, O'Brien TD, Jordan K, Westermark P (1989) Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Pathol 135: 245?250","journal-title":"Am J Pathol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00400933","volume":"35","author":"J Eriksson","year":"1992","unstructured":"Eriksson J, Nakazato M, Miyazato M, Shiomi K, Matsukura S, Groop L (1992) Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulindependent) diabetes mellitus. Diabetologia 35: 291?293","journal-title":"Diabetologia"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI114528","volume":"85","author":"A Ogawa","year":"1990","unstructured":"Ogawa A, Harris V, McCorkle SK, Unger RH, Luskey KL (1990) Amylin secretion from the rat pancreas and its selective loss after streptozotocin. J Clin Invest 85: 973?976","journal-title":"J Clin Invest"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00400917","volume":"35","author":"I Swenne","year":"1992","unstructured":"Swenne I (1992) Pancreatic beta-cell growth and diabetes. Diabetologia 35: 193?201","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00399099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00399099\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00399099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T16:58:05Z","timestamp":1682787485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00399099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF00399099"],"URL":"https:\/\/doi.org\/10.1007\/bf00399099","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}